Identification and Management of Night Eating Syndrome in the Adolescent and Young Adult Population

Instructions

Click the red REGISTER button to pay the $10 fee and take the posttest
Click here to return to the PCC CME article 

Overview

Night eating syndrome is a condition that requires early identification and management, especially among adolescents who develop symptoms during the transition into adulthood.


Read the whole article at psychiatrist.com here: 
Identification and Management of Night Eating Syndrome in the Adolescent and Young Adult Population 

© Copyright 2022 Physicians Postgraduate Press, Inc.

Target Audience

Primary care clinicians

Learning Objectives

Screen for for night eating behaviors in teenagers and young adults with depression, anxiety, eating disorders, or sleep disorders and those under stress

Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
02/17/2022
Activity expires: 
02/29/2024
Cost:
$10.00
Rating: 
0

CME Background

Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.

CME Objective

After studying this article, you should be able to:

  • Screen for night eating behaviors in teenagers and young adults with depression, anxiety, eating disorders, or sleep disorders and those under stress

Statement of Need and Purpose

Night eating syndrome may develop during the late adolescent/young adult period. Young adults with depression, anxiety, other eating disorders, or sleep disorders and those under increased stress should be screened for night eating behaviors. Early treatment of depression can help prevent development of night eating syndrome. Those with night eating syndrome can be managed with cognitive-behavioral therapy or selective serotonin reuptake inhibitors. Because the condition is often not diagnosed until adulthood when it is often accompanied by complications such as depression and overweight, practitioners need education about strategies to recognize and prevent or treat night eating syndrome closer to the time of onset.

Release, Expiration, and Review Dates

This educational activity was published in February 2022 and is eligible for AMA PRA Category 1 Credit™ through February 29, 2024 . The latest review of this material was February 2022.

Disclosure of Off-Label Usage

The authors have determined that, to the best of their knowledge, SSRIs, Cognitive-Behavioral Therapy, Bright Light Therapy, topiramate, and agomelatine are not approved by the US Food and Drug Administration for the treatment of Night Eating Syndrome. 

Funding/Support

None

Faculty Affiliation


Thomas Lepley, BS
Central Michigan University, College of Medicine, Mt. Pleasant, Michigan



Zachary Schwager, MD
Department of Psychiatry, Central Michigan University, Saginaw, Michigan



Zaira Khalid, MD
Department of Psychiatry, Central Michigan University, Saginaw, Michigan

 

*Corresponding author: Thomas Lepley, BS, 1280 East Campus Drive, Mt. Pleasant, MI 48858 (leple1tj@cmich.edu).

Financial Disclosure

All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past year, Larry Culpepper, MD, MPH, Editor in Chief of The Primary Care Companion for CNS Disorders, has been a consultant for AbbVie, Acadia, Allergan, Eisai, Merck, and Takeda; has been a stock shareholder of M-3 Information; and has received royalties from UpToDate and Oxford University Press. No member of the CME Institute staff reported any relevant personal financial relationships.

Drs Lepley, Schwager, and Khalid have no financial relationships relevant to this article to disclose.

Accreditation Statement

The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$10.00
Please login or register to take this activity.

Register for free on our site to participate in this and many free CME courses. There is a $10 processing fee for this activity.